Aimee DeFilippo’s practice is entirely devoted to antitrust and competition law. She has experience working on government investigations into prospective and post-consummated mergers and acquisitions, as well as responding to nonmerger government investigations before the Federal Trade Commission, the Antitrust Division of the U.S. Department of Justice, and various state attorneys general. She also counsels clients on antitrust issues involving information sharing, pricing, and distribution. She has represented clients in a variety of industries, including health care, pharmaceuticals, agriculture, computer software, electronics, and communications. Aimee is a member of the American Bar Association’s Section of Antitrust Law, and also serves in a leadership role with the Antitrust Practice Group of the American Health Lawyers Association. She has written extensively for these organizations, both as a contributing author for several ABA books and AHLA publications and as a publisher of articles in The Antitrust Source, The Threshold, and others. She has also appeared as a panelist in several ABA and AHLA programs. Aimee is a member of the Virginia Bar and the District of Columbia Bar.
59
In Short The Development: Congress unanimously passed and before leaving office, President Trump signed into law, the Competitive Health Insurance Reform Act ("CHIRA"). CHIRA limits application of the McCarran-Ferguson Act, an exemption from the federal antitrust laws, as it relates to the (...)
48
This article has been nominated for the 2020 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. In Short The Situation: The Federal Trade Commission ("FTC") recently filed a rare monopolization case, alleging that a health information technology company (...)
659
Just two weeks after the FTC filed a complaint seeking an injunction to stop the proposed $3.1 billion acquisition by Australia-based CSL Limited of Talecris Biotherapeutics Holding Corporation, the parties have withdrawn their plans for a merger. The announcement, made on June 8, 2009, came (...)
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 144
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK
